1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3. |
Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol, 2011, 12(7): 681-692.
|
4. |
Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet, 2016, 388(10060): 2654-2664.
|
5. |
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 2015, 385(9972): 977-1010.
|
6. |
Ren G, Cai R, Zhang WJ, et al. Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol, 2013, 19(20): 3096-3107.
|
7. |
Saad F, Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol, 2012, 8(3): 321-331.
|
8. |
Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature, 2016, 529(7586): 298-306.
|
9. |
Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene, 2016, 35(10): 1216-1224.
|
10. |
Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett, 2007, 253(2): 180-204.
|
11. |
Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods, 2010, 50(4): 289-297.
|
12. |
Allard WJ, Matera J, Miller MC, et a1. Tumor cells circulate in theperi pheral blood of all major carcinom as but not in healthy subjects orpatients with nonmalignant diseases. Clin Cancer Res, 2004, 10(20): 6897-6904.
|
13. |
中华人民共和国卫生部. 胃癌诊断标准(WS316-2010). 北京: 中国标准出版社, 2010.
|
14. |
廖专, 孙涛, 吴浩, 等. 中国早期胃癌筛查及内镜诊治共识意见(2014年4月·长沙). 胃肠病学, 2014, 34(7): 408-427.
|
15. |
Yang C, Zou K, Yuan Z, et al. Prognostic value of circulating tumor cells detected with the CellSearch system in patients with gastric cancer: evidence from a meta-analysis. Onco Targets Ther, 2018, 11: 1013-1023.
|
16. |
Yang C, Zhang N, Wang S, et al. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer. J Transl Med, 2018, 16(1): 139.
|
17. |
Okabe H, Tsunoda S, Hosogi H, et al. Circulating tumor cells as an independent predictor of survival in advanced gastric cancer. Ann Surg Oncol, 2015, 22(12): 3954-3961.
|
18. |
Zheng L, Zou K, Yang C, et al. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients. Clin Transl Oncol, 2017, 19(9): 1125-1132.
|
19. |
韩鸿彬, 李朝辉, 刘帅锋, 等. 胃癌患者外周血循环肿瘤细胞检测及其临床意义. 中国普外基础与临床杂志, 2015, 22(7): 840-843.
|
20. |
曹中正, 丁连安, 牛冬光, 等. 胃癌外周血循环肿瘤细胞水平及其临床意义. 临床肿瘤学杂志, 2014, 19(6): 539-542.
|
21. |
Kubisch I, de Albuquerque A, Schuppan D, et al. Prognostic role of a multimarker analysis of circulating tumor cells in advanced gastric and gastroesophageal adenocarcinomas. Oncology, 2015, 89(5): 294-303.
|